Mark Schoenberg, the Chief Medical Officer of $URGN, sold 1,896 shares of the company on 01-31-2025 for an estimated $21,121. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.3% of their shares of this class of stock. Following this trade, they now own 148,540 shares of this class of $URGN stock.
$URGN Insider Trading Activity
$URGN insiders have traded $URGN stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $URGN stock by insiders over the last 6 months:
- JASON DREW SMITH (General Counsel) has made 0 purchases and 4 sales selling 8,900 shares for an estimated $102,096.
- MARK SCHOENBERG (Chief Medical Officer) has made 0 purchases and 4 sales selling 5,410 shares for an estimated $61,933.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$URGN Hedge Fund Activity
We have seen 71 institutional investors add shares of $URGN stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. removed 3,083,430 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $39,159,561
- GREAT POINT PARTNERS LLC removed 2,147,473 shares (-73.9%) from their portfolio in Q3 2024, for an estimated $27,272,907
- POINT72 ASSET MANAGEMENT, L.P. removed 942,631 shares (-38.5%) from their portfolio in Q3 2024, for an estimated $11,971,413
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 435,741 shares (+13.2%) to their portfolio in Q3 2024, for an estimated $5,533,910
- VESTAL POINT CAPITAL, LP added 400,000 shares (+inf%) to their portfolio in Q3 2024, for an estimated $5,080,000
- MORGAN STANLEY added 342,758 shares (+18.6%) to their portfolio in Q3 2024, for an estimated $4,353,026
- MILLENNIUM MANAGEMENT LLC added 338,302 shares (+29.1%) to their portfolio in Q3 2024, for an estimated $4,296,435
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.